Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
2022 · JAMA · 149 citations
https://doi.org/10.1001/jama.2022.2910
D
David Orlikowski
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
266
Papers
6.5K
Citations
46
h-index
129
i10-index
David Orlikowski is an academic researcher from Hôpital Raymond-Poincaré. The author has contributed to research in topics: Respiratory Support and Mechanisms & Muscle Physiology and Disorders & Peripheral Neuropathies and Disorders. The author has an h-index of 46, co-authored 227 publications.
ORCID: 0000-0003-3332-0580Papers by this author
worksLong-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022 · JAMA · 134 citations
https://doi.org/10.1001/jama.2022.23257
Science review: The brain in sepsis - culprit and victim
2004 · Critical Care · 114 citations
https://doi.org/10.1186/cc2951
Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature
2017 · Orphanet Journal of Rare Diseases · 104 citations
https://doi.org/10.1186/s13023-017-0598-0
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021 · Intensive Care Medicine · 96 citations
https://doi.org/10.1007/s00134-021-06448-5
Nocturnal Oximetry and Transcutaneous Carbon Dioxide in Home-Ventilated Neuromuscular Patients
2012 · Respiratory Care · 52 citations
https://doi.org/10.4187/respcare.01658
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat